Race for the Cure
How to Raise Funds
Gifts of Stock
Shop for the Cure
Celebrate and Remember
Spread the Word
Calendar of Events
Mission and Education
Breast Cancer Overview
Research and Clinical Trials
Patient and Family Resources
Screening and Detection
Susan G. Komen for the Cure
Karmanos Cancer Institute
Calendar of Events
2013 Race Results
It's CASH that leads to CURES. Donate TODAY!
We LIVE here. We RACE here. We SAVE LIVES here.
2013 Komen Detroit Runners' Race Results
Courtesty of Motor City Striders, the final timed results for the runners from the 5K Race on May 18th have been released.
2013 Detroit Deals
After you're finished with the Race, please stop by one of the local businesses, which are offering incentives to patrons wearing 2013 Race t-shirts.
One-Stop Registration Locations & Packet Pickup
Here's information on where you can pick up your packets before Race day, whether you've already registered or need to register for "the BEST day in the city of Detroit."
Ways to Help
Passionately Pink for the Cure
Passionately Pink for the Cure® is an awareness and fundraising program benefiting Susan G. Komen for the Cure®.
Rally for the Cure®
Rally for the Cure is a grassroots program that works to spread awareness about breast cancer in support of Susan G. Komen through volunteer organized golf, tennis and social events.
3-Day and Be Bold: Register for the Susan G. Komen 3-Day®
Coming to Michigan August 16-18, the Komen 3-Day is a 60-mile walk for women and men who want to be a part of something bigger - ending breast cancer forever. Participants raise a minimum of $2,300 and walk an average of 20 miles a day for three consecutive days.
30,000 took part in the 22nd Annual Komen Detroit Race for the Cure®, May 18
A crowd of 30,000 participated in this year's 22nd Annual Susan G. Komen Detroit Race for the Cure®, locally presented by the Barbara Ann Karmanos Cancer Institute.
First Annual ACCESS Celebrating Life Breakfast
ACCESS will host its first annual Celebrating Life Breakfast to raise awareness about breast cancer in the Arab American community on June 1, 2013 from 10 a.m.-1 p.m.
Kadcyla: A new drug for Patients with Late-Stage HER2+ Metastatic Breast Cancer
The U.S. Food and Drug Administration has approved Kadcyla, also known as T-DM1, as an option for some patients who are not responding to other treatments. The drug was developed with the help of Patricia LoRusso, D.O.
KOMEN DETROIT RACE FOR THE CURE© MAILING ADDRESS: 4100 John R, Detroit, MI 48201; MC: VE01RF
PHONE: 248-304-2080 or 800-KARMANOS (800-527-6266) ·
Help & FAQs
Report Improper Conduct